Determining The Value of Selexipag For The Treatment of Pulmonary Arterial Hypertension (PAH) In Spain By Multi-Criteria Decision Analysis (MCDA)
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.971
https://www.valueinhealthjournal.com/article/S1098-3015(17)31305-0/fulltext
Title :
Determining The Value of Selexipag For The Treatment of Pulmonary Arterial Hypertension (PAH) In Spain By Multi-Criteria Decision Analysis (MCDA)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31305-0&doi=10.1016/j.jval.2017.08.971
First page :
A570
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
930